E. L. Matteson

2.3k total citations
36 papers, 1.6k citations indexed

About

E. L. Matteson is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, E. L. Matteson has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Pathology and Forensic Medicine. Recurrent topics in E. L. Matteson's work include Systemic Lupus Erythematosus Research (12 papers), Vasculitis and related conditions (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). E. L. Matteson is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Vasculitis and related conditions (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). E. L. Matteson collaborates with scholars based in United States, United Kingdom and Sweden. E. L. Matteson's co-authors include Carl Turesson, W. Michael O’Fallon, Kenneth J. Warrington, Cynthia S. Crowson, Carlo Salvarani, Tanaz A. Kermani, Francesco Muratore, C. S. Crowson, Robert W. Ike and Tim Bongartz and has published in prestigious journals such as Gastroenterology, Radiology and Annals of the Rheumatic Diseases.

In The Last Decade

E. L. Matteson

34 papers receiving 1.6k citations

Peers

Countries citing papers authored by E. L. Matteson

Since Specialization

Citations

This map shows the geographic impact of E. L. Matteson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. L. Matteson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. L. Matteson more than expected).

Fields of papers citing papers by E. L. Matteson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. L. Matteson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. L. Matteson. The network helps show where E. L. Matteson may publish in the future.

Co-authorship network of co-authors of E. L. Matteson

This figure shows the co-authorship network connecting the top 25 collaborators of E. L. Matteson. A scholar is included among the top collaborators of E. L. Matteson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. L. Matteson. E. L. Matteson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis 2023 ·Seminars in Arthritis and Rheumatism ·(unknown), (unknown), Lutz Beckert, (unknown), E. L. Matteson, Chris Frampton, (unknown)	20
2	FRI0687 Body mass index, smoking, socioeconomic status and the risk of giant cell arteritis 2017 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), (unknown), Kenneth J. Warrington, E. L. Matteson, Carl Turesson	1
3	FRI0278 Prevalence of primary sjÖgren's syndrome in a population-based cohort in the united states 2017 ·Annals of the Rheumatic Diseases ·(unknown), Cynthia S. Crowson, E. L. Matteson, Divi Cornec	0
4	Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota 2017 ·Reumatismo ·Patompong Ungprasert, C. S. Crowson, E. L. Matteson	31
5	The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009 2015 ·Scandinavian Journal of Rheumatology ·(unknown), (unknown), C. S. Crowson, Kenneth J. Warrington, E. L. Matteson	67
6	SAT0341 Polymyalgia Rheumatica and its Association with Cancer 2015 ·Annals of the Rheumatic Diseases ·(unknown), C. S. Crowson, Brittny Major, E. L. Matteson	1
7	Large-vessel giant cell arteritis: a cohort study 2014 ·Lara D. Veeken ·Francesco Muratore, Tanaz A. Kermani, Cynthia S. Crowson, (unknown), Carlo Salvarani, E. L. Matteson, Kenneth J. Warrington	233
8	Vasculitis associated with rheumatoid arthritis: a case-control study 2014 ·Lara D. Veeken ·Ashima Makol, Cynthia S. Crowson, David A. Wetter, Olayemi Sokumbi, E. L. Matteson, Kenneth J. Warrington	72
9	FRI0353 Incidence of giant cell arteritis in the current era of advanced diagnostic imaging 2013 ·Annals of the Rheumatic Diseases ·(unknown), Cynthia S. Crowson, Kenneth J. Warrington, E. L. Matteson	1
10	Malignancy as a comorbidity in rheumatic diseases 2012 ·Lara D. Veeken ·Carl Turesson, E. L. Matteson	78
11	Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years 2011 ·Annals of the Rheumatic Diseases ·Mahboob U. Rahman, Jacqueline Buchanan, Mittie K. Doyle, E. C. Hsia, (unknown), Shreekant Parasuraman, Daniel Aletaha, E. L. Matteson, Philip G. Conaghan, Edward Keystone, D. van der Heijde, Josef S Smolen	61
12	GOLIMUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION AND FATIGUE IN RA PATIENTS PREVIOUSLY TREATED WITH ANTI-TNF AGENTS: RESULTS FROM THE GO-AFTER STUDY 2010 ·Lara D. Veeken ·(unknown), P Wordsworth, Mittie K. Doyle, J. Smolen, Jacqueline Buchanan, E. L. Matteson, E. C. Hsia, Robert Landewé, (unknown), (unknown), (unknown), (unknown)	3
13	Incidence of herpes zoster in patients with giant cell arteritis: a population-based cohort study 2010 ·Lara D. Veeken ·Valentin Sebastian Schäfer, Tanaz A. Kermani, Cynthia S. Crowson, Gene G. Hunder, S. E. Gabriel, Steven R. Ytterberg, E. L. Matteson, Kenneth J. Warrington	11
14	The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases 2010 ·Lara D. Veeken ·Hilal Maradit Kremers, (unknown), Cynthia S. Crowson, (unknown), S. E. Gabriel, E. L. Matteson	31
15	Localized vasculitis of the gastrointestinal tract: a case series 2010 ·Lara D. Veeken ·Carlo Salvarani, Kenneth Calamia, C. S. Crowson, Dylan V. Miller, (unknown), Gene G. Hunder, E. L. Matteson, Kenneth J. Warrington	44
16	Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials 2008 ·Annals of the Rheumatic Diseases ·Tim Bongartz, Fiona C Warren, Daniel Mines, E. L. Matteson, Keith R. Abrams, Alex J. Sutton	116
17	Subcutaneous injection of CNTO 148 compared with placebo in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, dose-ranging trial. 2005 ·Digital Access to Libraries ·Jonathan Kay, Patrick Durez, E. L. Matteson, B. Dasgupta, Peter Nash, Stephen Hall, (unknown), (unknown)	1
18	Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years 2003 ·Annals of the Rheumatic Diseases ·Carl Turesson, W. Michael O’Fallon, (unknown), (unknown), E. L. Matteson	445
19	Connective tissue activation. xxxvi. the origin, variety, distribution, and biologic fate of connective tissue activating peptide–iii isoforms: characteristics in patients with rheumatic, renal, and arterial disease 1993 ·Arthritis & Rheumatism ·C. William Castor, Philip Andrews, Richard D. Swartz, Stephen G. Ellis, Paul A. Hossler, (unknown), E. L. Matteson, (unknown)	20
20	Clinically occult avascular necrosis of the hip: prevalence in an asymptomatic population at risk. 1992 ·Radiology ·Osmo Tervonen, (unknown), E. L. Matteson, Jorge A. Velosa, William W. Ginsburg, Richard L. Ehman	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact